Signing Ceremony by Chengde Medical University Affiliated Hospital & Shanghai Biotecan Medical Pharmaceuticals Co., Ltd


April 14, 2017, Chengde Medical University Affiliated Hospital and Shanghai Biotecan Medical Pharmaceuticals Co., Ltd. attended a signing ceremony in the South District of Chengde Medical University Affiliated Hospital, commit to build "Chengde Regional Molecular Medicine Center together."


Changlai Hao the chairman of Affiliated Hospital of CHENGDE Medical College、Yu Changyu-The Assistant Dean of CHENGDE Medical Unversity Affiliated Hospital、Jingwei Lou-the President of Biotecan、Baoyu Wang Vice President 、Lvning Sui Director 、 Xiaoli Li Supervisor、 Yanfu Jin Deputy General Manager, Yuji Ma Director attended the signing ceremony. The ceremony was chaired by Changyu Yu –the Assistant Dean of of ChengDe Medical University Affiliated Hospital .


The chairman Hao Changli mentioned:” At present, the ChengDe Medical University Affiliated Hospital is in an important historical period of the construction of domestic advanced research hospital, regional medical center and medical talents training base. It is an important & big milestone to promote the transformation and development of the hospital to collaborate with Biotecan to construct “Chengde Regional Molecular Medicine Center”, and it will promote the hospital’s research level of the and accelerate relevant technology development. With the joint efforts of all of us, the Regional Center for Molecular Medicine will achieve good social and economic benefits, and brings the Chengde’s precision medicine new level.”

In the warm applause, the President of Jingwei Lou and the chairman of Hao Changlai signed the contract. Later, Dr. Jingwei Lou gave a wonderful lecture on precision medicine.


This collaboration marks a new page in the development of Chengde precision medicine! The two sides will be based on the principle of win-win cooperation, make full use of CHENGDE Medical University Affiliated Hospital‘s rich medical resources, also with the help of Biotecan company’s strong technical strength, to develop the leading in China’s high-throughput sequencing center、large precision medical data center and high-end precision medicine health management center of covering molecular medicine, health management and innovation of medical service . At the same time, under the lead of Chengde city government, construct clinical molecular diagnostic reference laboratory network which covers the whole city hospital together, develop into a leading domestic large-scale regional molecular medicine testing center ,with a variety of major disease screening, molecular classification, individualized treatment, curative effect prediction and monitoring, and other functions, and gradually built a leading domestic and world-class precision medical large data platform ,provide a wide range of major disease screening、individualized diagnosis and treatment and exact curative effect evaluation and other services to local patients, promote development of the Chengde area of major diseases clinical treatment and precision medical industrialization .

  • Contact Us
  • Shanghai Biotecan Pharmaceuticals Co. , Ltd.
  • Telephone:+86-21-50277725
  • Address

    First Shanghai Centre, 180 Zhangheng Rd., Pudong New District, Shanghai, China

Copyright © 2015-2018 Shanghai Biotecan Pharmaceuticals Co.,Ltd All Rights Reserved 沪ICP备09055310号-1 沪公网安备 31011502003232号